For a drug with a global market value projected at $58.4 billion by 2035 , the arithmetic is difficult to process
Uses Approved Uses: Major Depressive Disorder, Generalized Anxiety Disorder, and more Cymbalta is a medication that belongs to the class of selective serotonin and norepinephrine reuptake inhibitors (SSNRIs) 1
Advances in in situ technologies for heterogeneity studies Spatial transcriptomics and in situ sequencing methods now enable transcriptional profiling within native tissue architecture, revealing positional information, disrupted localization, and altered niche interactions with aging
The analysis of more than 26,000 adults in the U.S
doi: 10.1001/jama.297.9.986 215 LongoVDAntebiABartkeABarzilaiNBrown-BorgHMCarusoCet al
Ozempic is FDA-approved for this indication